Cox models: remaining variables for overall survival and for disease-free survival
. | RH (95% CI) . | P . |
|---|---|---|
| Overall survival | ||
| No prior AIDS-defining illness, versus yes | 0.41 (0.18-0.94) | .036 |
| Diagnosis 1997-2004, versus 1989-1996 | 0.34 (0.16-0.69) | .003 |
| Post-GC differentiation, versus activated GC or GC | 3.98 (1.45-10.93) | .007 |
| Low IPI, versus high | 0.37 (0.18-0.76) | .007 |
| Disease-free survival | ||
| Post-GC differentiation, versus activated GC or GC | 35.20 (4.32-287.05) | .001 |
| Low IPI, versus high | 0.33 (0.13-0.81) | .015 |
. | RH (95% CI) . | P . |
|---|---|---|
| Overall survival | ||
| No prior AIDS-defining illness, versus yes | 0.41 (0.18-0.94) | .036 |
| Diagnosis 1997-2004, versus 1989-1996 | 0.34 (0.16-0.69) | .003 |
| Post-GC differentiation, versus activated GC or GC | 3.98 (1.45-10.93) | .007 |
| Low IPI, versus high | 0.37 (0.18-0.76) | .007 |
| Disease-free survival | ||
| Post-GC differentiation, versus activated GC or GC | 35.20 (4.32-287.05) | .001 |
| Low IPI, versus high | 0.33 (0.13-0.81) | .015 |
RH indicates relative hazards for death from any cause (overall survival) and for relapse or death from any cause (disease-free survival); GC, germinal center; IPI, International Prognostic Score.